“Biochemical, Hematological and Immunological Indices Among MDR-TB on Second Line Anti TB and MDR-TB-HIV Co-Infected Patients on Second Line Anti TB and ARV Drugs for a Six -Month Treatment”. Tanzania Medical Journal, vol. 31, no. 3, Oct. 2020, pp. 1-14, https://doi.org/10.4314/tmj.v31i3.359.